Intermittent Ephedrine Boluses for Prophylaxis Against Postinduction Hypotension
Intermittent Ephedrine Boluses for Prophylaxis Against Postinduction Hypotension in High-risk Patients Undergoing Major Abdominal Surgery: a Randomized Double-blinded Controlled Trial: a Randomized Double-blinded Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Maha Mostafa, MD
- Phone Number: +201000365115
- Email: maha.mostafa@cu.edu.eg
Study Locations
-
-
-
Cairo, Egypt, 11562
- Recruiting
- Kasr Alainy Hospital
-
Contact:
- ahmed hasanin
- Phone Number: +2 01095076954
- Email: ahmedmohamedhasanin@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patients aged >50 years,
- weight >50 kg,
- American Society of Anesthesiologists (ASA) Physical Status score of > I,
- undergoing major abdominal surgery
Exclusion Criteria:
- Severe cardiac morbidities (impaired contractility with ejection fraction < 40%, heart block, significant uncontrolled arrhythmias, tight stenotic valvular lesions)
- Acute cardiovascular pathologies: acute/decompensated heart failure, acute coronary syndrome
- Uncontrolled hypertension (systolic blood pressure>150 mmHg)
- Preoperative HR more than 110 bpm despite proper fluid management and patients with renal impairment
- Renal impairment
- Patients on vasopressor infusion,
- Allergy of any of the study drugs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: control
Normal Saline boluses
|
four 10-mL syringes of normal saline, The patient will receive the first dose of the intervention with induction (0.1 ml/kg).
After induction of anesthesia, the study drug will be given every 5 min for 20 min and will be withheld if MAP was ≥80 mmHg or if any vasopressor is given within 2 min of the current scheduled dose
|
|
Active Comparator: ephedrine
ephedrine boluses
|
four 10-mL syringes of ephedrine 1 mg/mL.
The patient will receive the first dose of the intervention with induction (0.1 ml/kg).
After induction of anesthesia, the study drug will be given every 5 min for 20 min and will be withheld if MAP was ≥80 mmHg or if any vasopressor is given within 2 min of the current scheduled dose.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of postinduction hypotension
Time Frame: from induction of anesthesia until 20 minutes after induction
|
mean arterial pressure < 65 mmHg
|
from induction of anesthesia until 20 minutes after induction
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
area under mean arterial pressure of 65 mmHg
Time Frame: from induction of anesthesia until 20 minutes after induction
|
from induction of anesthesia until 20 minutes after induction
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MD-160-2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.